These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17120478)

  • 1. Considerations on the potential teratogenic effects of antiretroviral therapy.
    Meli M; Vicidomini S; Bartoloni A
    Intern Emerg Med; 2006; 1(3):249-50. PubMed ID: 17120478
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP
    J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from the 11th conference on retroviruses and opportunistic infections.
    Laurence J
    AIDS Read; 2004 Apr; 14(4):151-3. PubMed ID: 15116693
    [No Abstract]   [Full Text] [Related]  

  • 4. What is the risk of major congenital abnormalities among women on antiretroviral therapy?
    Zash RM; Williams P; Holmes LB
    AIDS; 2018 Jan; 32(3):403-404. PubMed ID: 29309347
    [No Abstract]   [Full Text] [Related]  

  • 5. Combined antiretroviral therapy during pregnancy and risk of congenital malformations.
    Frieden IJ; Haggstrom AN; McCulloch C; Drolet B; Esterly NB; Garzon MC; Lucky AW; Baselga E; Friedlander SF
    JAMA; 2004 Apr; 291(16):1961-2; author reply 1962. PubMed ID: 15113813
    [No Abstract]   [Full Text] [Related]  

  • 6. The safety of antiretroviral drugs in pregnancy.
    Thorne C; Newell ML
    Expert Opin Drug Saf; 2005 Mar; 4(2):323-35. PubMed ID: 15794723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preconception antiretroviral therapy and birth defects: what is needed?
    Bulterys M; Berry RJ; Watts DH
    AIDS; 2014 Nov; 28(18):2777-80. PubMed ID: 25493603
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of mother-to-child transmission.
    Surjushe A; Maniar J
    Indian J Dermatol Venereol Leprol; 2008; 74(3):200-7. PubMed ID: 18583783
    [No Abstract]   [Full Text] [Related]  

  • 9. [HAART and pregnancy. Nelfinavir superiority in hepatotoxicity].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():45. PubMed ID: 15373048
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitochondrial disease in the offspring as a result of antiretroviral therapy.
    Venhoff N; Walker UA
    Expert Opin Drug Saf; 2006 May; 5(3):373-81. PubMed ID: 16610967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.
    Pinnetti C; Tintoni M; Ammassari A; Tamburrini E; Bernardi S; Liuzzi G; Scambia G; Perno CF; Floridia M; Antinori A; Cavaliere AF
    AIDS; 2015 Nov; 29(18):2534-7. PubMed ID: 26372490
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
    Coovadia H
    N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Thorne C; Fiore S; Rudin C
    N Engl J Med; 2003 Jan; 348(5):471-2; author reply 471-2. PubMed ID: 12556551
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects and complications. Risk of deformities very low in infants exposed to HAART.
    TreatmentUpdate; 2009 Feb; 21(2):8-9. PubMed ID: 19391265
    [No Abstract]   [Full Text] [Related]  

  • 17. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral Therapy and Adverse Pregnancy Outcome: The Elephant in the Room?
    Mofenson LM
    J Infect Dis; 2016 Apr; 213(7):1051-4. PubMed ID: 26265779
    [No Abstract]   [Full Text] [Related]  

  • 19. Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy.
    Floridia M; Guaraldi G; Ravizza M; Tibaldi C; Pinnetti C; Maccabruni A; Molinari A; Liuzzi G; Alberico S; Meloni A; Rizzi L; Dalzero S; Tamburrini E;
    Clin Infect Dis; 2015 Jan; 60(1):159-61. PubMed ID: 25230994
    [No Abstract]   [Full Text] [Related]  

  • 20. Protecting the next generation--eliminating perinatal HIV-1 infection.
    Mofenson LM
    N Engl J Med; 2010 Jun; 362(24):2316-8. PubMed ID: 20554987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.